Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cystic fibrosis screening.

Lee P Shulman1

  • 1Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. lps5@cornell.edu

Journal of Midwifery & Women'S Health
|May 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remdesivir Use During Pregnancy: Findings From the Prospective COVID-19 International Drug Pregnancy Registry and Narrative Literature Review.

Journal of pregnancy·2026
Same author

Comparative Efficacy of Elinzanetant Versus Other Non-Hormonal Pharmaceutical Therapies for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause: A Network Meta-Analysis.

BJOG : an international journal of obstetrics and gynaecology·2026
Same author

Efficacy and safety of casirivimab/imdevimab (REGEN-COV) in pregnant individuals with COVID-19: Literature review and insights from the COVID-19 International Drug Pregnancy Registry.

Obstetric medicine·2025
Same author

Why does the latest pharmacovigilance data not reflect clinical experience with dydrogesterone?

Human reproduction open·2025
Same author

Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen<sup>®</sup> and Smart B<sup>®</sup> in Women with Climacteric Syndrome in Perimenopause.

Advances in therapy·2024
Same author

Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry.

Drug safety·2024

Universal cystic fibrosis screening in women's health is transforming obstetric care and paving the way for broader genetic testing. This shift highlights the need for robust programs supporting informed patient decisions and effective genetic information dissemination.

Area of Science:

  • Reproductive Medicine
  • Medical Genetics
  • Public Health

Background:

  • Genetic screening was historically limited to individuals with family history or specific ethnic backgrounds.
  • Technological advancements have enabled more accessible and affordable genetic mutation detection.

Purpose of the Study:

  • To examine the impact of universal cystic fibrosis screening on women's health and obstetric care.
  • To underscore the necessity of programs for implementing genetic protocols and facilitating informed patient choices.

Main Methods:

  • Analysis of the integration of universal cystic fibrosis screening into standard women's health protocols.
  • Evaluation of the implications of widespread genetic testing in the general population.

Main Results:

Related Experiment Videos

  • Universal cystic fibrosis screening has significantly altered obstetric patient care.
  • This integration serves as a model for incorporating other genetic tests into routine healthcare.

Conclusions:

  • Widespread genetic testing is becoming a future standard in healthcare.
  • Clinicians must recognize the benefits and challenges of population-wide genetic testing.
  • Development of effective communication programs for genetic information is crucial for both professionals and the public.